JPRN-UMIN000050152
Completed
未知
Clinical study to confirm anti-sarcopenia effect of test food. - Clinical study to confirm anti-sarcopenia effect of test food.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- EP Mediate Co., Ltd
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Subjects (1\) who have or have a history of any disease that may affect the evaluation of the study (2\) who have difficulty in daily activities or walking due to severe pain, or who are unable to perform exercise training (3\) diagnosed with sarcopenia (4\) who have a possibility of recurrence of locomotory disease due to exercise training (5\) who regularly use health foods that may affect the evaluation of the study (6\) who regularly use pharmaceuticals (7\) who exercise regularly (8\) who exercise excessively (9\) with a history of locomotory disease within 1 year before the screening examination (10\) who use canes or supporters (11\) who periodically conduct actions that may affect the evaluation of effectiveness (12\) who are under treatment of diseases on the joints (13\) who have or have a history of severe diseases (14\) who are under treatment or have a history of mental diseases (15\) who have unsteady lifestyle or who work manual labor (16\) who drink a lot (17\) who have possibilities for emerging allergy onset related to the study (18\) who are judged as unsuitable for the study based on the results of screening examination (19\) who have participated in other clinical study within a month before the screening test or who intend to participate in the study period (20\) who are in a pregnancy or lactation period in the study period (21\) who are judged as unsuitable due to lifestyle questionnaire (22\) who cannot carry out the test as instructed (23\) who are judged as unsuitable for the study by investigator for other reasons
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A clinical study on the potential therapeutic effects of intramuscular injection of G-CSF on the athlete patients with muscle strain injurymuscle strain injuryJPRN-UMIN000017506Keio University School of Medicine60
Completed
Phase 2
Clinical study to investigate the therapeutic effect of 1-kestose on atopic dermatitisAtopic dermatitisJPRN-UMIN000008858Tokai University School of Medicine120
Completed
Not Applicable
Clinical investigations of the therapeutic effect of an elemental diet for and the blood amino acid level changes of patients with inflammatory bowel diseaseCrohn's disease, Ulcerative colitisJPRN-UMIN000016792Dokkyo Medical University40
Active, not recruiting
Phase 3
Clinical study to assess how well wilate works in the regular treatment of young children with severe von Willebrand diseaseISRCTN11217735Octapharma (Austria)12
Active, not recruiting
Phase 1
Clinical study to investigate the efficacy, the safety and immunogenicity of Wilate in children <6 years of age with inherited von Willebrand disease (VWD) - WIL-14Wllebrand diseaseMedDRA version: 8.1Level: PTClassification code 10047715Term: Von Willebrand's diseaseEUCTR2005-001426-84-FROCTAPHARMA AG17